Biomimetic total synthesis of the ACAT inhibitor (+)-pyripyropene E

Tetrahedron Letters

Volumn 37, Issue 36, 1996, Pages 6461-6464

  Smith III, Amos B ^a   Kinsho, Takeshi ^b   Sunazuka, Toshiaki ^d   Omura, Satoshi ^c  

^a MONELL CHEMICAL SENSES CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KITASATO INSTITUTE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE INHIBITOR; ENZYME INHIBITOR; PYRIPYROPENE E; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0030565604     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)01439-6     Document Type: Article

References (32)

1. (a) Ōmura, S.; Tomoda, H.; Kim, Y.-K.; Nishida, H. J. Antibiot. 1993, 46, 1168.
2. (b) Tomoda, H.; Kim, Y.-K.; Nishida, H.; Masuma, R.; Ōmura, S. J. Antibiot. Ibid. 1994, 47,148.
3. Kim, Y.-K.; Tomoda, H.; Nishida, H.; Sunazuka, T.; Obata, R.; Ōmura, S. J. Antibiot. Ibid. 1994, 47, 154. (
4. Tomoda, H.; Tabata, N.; Yang, D.-J.; Takayanagi, H.; Nishida, H.; Ōmura, S. J. Antibiot. Ibid 1995, 48, 495.
5. (a) Tomoda, H.; Nishida, H.; Kim, Y.-K.; Obata, R.; Sunazuka, T.; Ōmura, S.; Bordner, J.; Guadliana, M.; Dormer, P. G.; Smith, A. B., III J. Am. Chem. Soc. 1994, 116, 12097.
6. (b) Nagamitsu T.; Sunazuka, T.; Obata, R.; Tomoda, H.; Tanaka, H.; Harigaya, Y.; Omura, S.; Smith, A. B., III J. Org. Chem. 1995, 60, 8126.
7. (a) Jeong, T.-S.; Kim, S.-U.; Kwon, B.-M.; Son, K.-H.; Kim, Y.-K.; Choi, M.-U.; Bok, S.-H. Tetrahedron. Lett. 1994, 35, 3569.
8. (b) Jeong, T.-S.; Kim, S.-U.; Son, K.-H.; Kwon, B.-M.; Kim, Y.-K.; Choi, M.-U.; Bok, S.-H. J. Antibiot. 1995, 48, 751.
9. Parker, K. A.; Resnick, L. J. Org. Chem. 1995, 60, 5726.
10. For reviews, see: (a) Sutherland, J. K. In Comprehensive Orgainc Synthesis-, Trost, B. M., Ed.; Pergamon: New York, 1991; Vol. 3, p. 341.
11. (b) Bartlett, P. A. In Asymmetric Synthesis; Morrison, J. D., Ed.; Academic: New York, 1984; Vol. 3, p. 341.
12. Johnson, W. S. Bioorg. Chem. 1976, 5, 51.
13. Harding, K. E. Bioorg. Chem. Ibid. 1973, 2, 248.
14. (e) van Tamelen, E. E. Acc. Chem. Res. 1968, 1, 111.
15. For leading references, see: Smith, A. B., III; Nolen, E. G.; Shirai, R.; Blase, F. R.; Ohta, M.; Chida, N.; Hartz, R. A.; Fitch, D. M.; Clark, W. M.; Sprengeler, P. A. J. Org. Chem. 1995, 60, 7837.
16. Vidari, G.; Dapiaggi, A.; Zanoni, G.; Garlaschelli, L. Tetrahedron Lett. 1993, 34, 6485.
17. Corey, E. J.; Noe, M. C.; Lin, S. Tetrahedron Lett. 1995, 36, 8741.
18. 13C NMR spectra, as well as appropriate parent ion identification by high resolution mass spectrometry.
19. (a) Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512.
20. (b) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092.
21. Corey reported 64% yield (80% based on recoved starting material) and 96% ee for the same transformation (reference 8). We thank Professor Corey for a preprint of reference 8 and a generous sample of 1,4-bis[O-6'-(4-heptyl)hydrocupreidyl] naphthopyridazine monomethiodide.
22. The use of methanesulfonic anhydride rather than methanesulfonyl chloride prevents possible racemization: Mori, K.; Mori, H. Tetrahedron 1987, 43, 4097.
23. Ohta, S.; Tsujimura, A.; Okamoto, M. Chem. Pharm. Bull. 1981, 29, 2762.
24. Mander, L. N.; Sethi, S. P. Tetrahedron Lett. 1983, 48, 5425.
25. 16 (47.5 mg, 24% yield).
26. 4: 410.2331].
27. 28 +113° (c 1.0, MeOH)}.
28. 5: 452.2436].
29. Carroll, P. J., University of Pennsylvania, unpublished results.
30. (a) Stork, G.; Burgstahler, A. W.; J. Am. Chem. Soc. 1955, 77, 5068.
31. (b) Eschenmoser, A.; Ruzicka, L.; Jeger, O.; Arigoni, D. Helv. Chim. Acta 1955, 38, 1890.
32. Stadler, P. A.; Eschenmoser, A.; Schintz, H.; Stork, G. Helv. Chim. Acta Ibid. 1957, 40, 2191.